Single Cell Analysis Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028
Single Cell Analysis Market |
A new method called Single Cell Analysis makes it possible to sequence the whole human genome at the level of a
single cell. In particular, with its sensitivity increased to single cell
level, this covers genomics, transcriptomics, proteomics, epigenomics, and
metabolomics. New generation techniques, including third generation sequencing
and next generation sequencing, are very important in the field of genomics.
Measurement and study of cellular heterogeneity are the main goals of single
cell analysis. Single
Cell Analysis Market explains life at its most basic level and has numerous
medical applications. The discovery and analysis of unidentified microorganisms
are made possible by single cell analysis as opposed to traditional standard
cell numbers sequencing.
According to a study published in
the Journal of Single Cell Analysis in 2014, a number of powerful and
affordable technologies, including Multiple Annealing and Looping-Based
Amplification Cycle (MALBAC) and Multiple Displacement Amplification (MDA),
have made significant strides in detecting copy number variation and somatic
mutations in the human genome. However, Whole Genome Sequencing or Whole Exome-Sequencing
(WGS or WESseq) in human single-cell genomics has a lot of potential for
clinical applications, particularly in screening, diagnosis, and monitoring.
Because mRNA shows gene functions and regulatory networks, bridges genome
structure and epigenomics modification with phenotype, and is easier to
accomplish than proteomics, it is well-liked in academic research.
Technology advances in
single-cell analysis products, rising cancer research funding, and recent
growth in the biotechnology and biopharmaceutical industries are all credited
with driving the Single Cell Analysis
Market.
One of the leading causes of
death worldwide is cancer. The disease has seen significant growth in recent
years, and over the forecast period, it is anticipated to grow quickly. The
World Health Organization (WHO) updated its key statistics in February 2022.
According to the WHO, cancer was the leading cause of death globally in 2020,
accounting for close to 10 million deaths, or close to one in every six. 40,0000
kids are diagnosed with cancer in children each year.
The most prevalent malignancies
differ between nations. As a result, the market is growing faster due to the
rising incidence of cancer around the world, which also increases the demand
for improved diagnoses of Single Cell Analysis Market. Additionally, the International
Agency for Research on Cancer (IARC) predicts that by 2040, there would be 16.3
million cancer-related deaths globally and 27.5 million new cancer diagnoses.
Since they may make it possible to track the development of cancer and modify
treatment, circulating tumour cells are also attracting more clinical
attention. The diagnostic and prognostic biomarkers were discovered by
single-cell sequencing research.
Major Companies involved are- 10X Genomics, Abcam Plc., Agilent
Technologies, Fluxion Biosciences, Becton, Dickinson and Company, Bio-Rad
Laboratories, Inc., Bio-Techne Corporation, Bruker, Danaher Corporation,
Fluidigm Corporation, GE Healthcare, and Illumina
Comments
Post a Comment